# Immunome Inc.: Form 8-K, filed Feb 6, 2024

- Company: [Immunome Inc.](/companies/imnm.md) (CIK 1472012)
- Form: 8-K
- Filed: 2024-02-06
- Accepted by EDGAR: Feb 6, 2024, 08:05 ET
- Period: 2024-02-05
- Accession: 0001104659-24-010945
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1472012/000110465924010945/tm245249d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1472012/000110465924010945/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1472012/000110465924010945/tm245249d1_8k.htm

Filed Feb 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-010945. Last ingested by Listed: Oct 30, 2026, 12:06 ET. No prices; not investment advice.